Healthcare Studies

Research Article

The Effect of Parity on Atherogenic Indices in Normotensive Pregnant Women at 2nd Trimester

  • By Tomaziga Tomiloba Oladapo-Akinfolarin, Oladapo Mayowa Akinfolarin, Maureen Chibuzor Maduagwu, Chikadibia Fyneface Amadi, Edna Ogechi Nwachukwu-Ibegbulem - 31 May 2023
  • Healthcare Studies, Volume: 1, Issue: 1, Pages: 39 - 46
  • Received: March 15, 2023; Accepted: May 19, 2023; Published: May 31, 2023


A physiological increase in plasma lipids occurs during normal pregnancy. However, this occurrence is not atherogenic because it is regulated by hormones. Although the majority of the changes that occur during pregnancy are transient, they do coincide with established cardiovascular disease (CVD) risk factors when it comes to parity. The focus on the study was to compare atherogenic indices among various groups of parity. Fifty normotensive pregnant female subjects were chosen at random from Rivers State University and the Rivers State University Teaching Hospital (RSUTH) for this study in their second trimester. They were divided into three groups; 20 nulliparous women, 13 primiparous women and 17 multiparous women. Blood was drawn for the analysis of atherogenic indices; atherogenic index of plasma (AIP), atherogenic coefficient (AC), Castelli Risk Index I and II (CRI1, CRI-2) and Apo B/Apo A1. The comparison was done and it was revealed that atherogenic indices showed no notable difference (p>0.05) in the parity groups. As a result, the study has reported that parity does not have any effect on the level of atherogenic markers in pregnant with normal blood pressure in RSUTH.